Ravindra Uppaluri

9.3k total citations · 2 hit papers
100 papers, 5.2k citations indexed

About

Ravindra Uppaluri is a scholar working on Oncology, Otorhinolaryngology and Immunology. According to data from OpenAlex, Ravindra Uppaluri has authored 100 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 37 papers in Otorhinolaryngology and 26 papers in Immunology. Recurrent topics in Ravindra Uppaluri's work include Head and Neck Cancer Studies (35 papers), Cancer Immunotherapy and Biomarkers (33 papers) and Immunotherapy and Immune Responses (16 papers). Ravindra Uppaluri is often cited by papers focused on Head and Neck Cancer Studies (35 papers), Cancer Immunotherapy and Biomarkers (33 papers) and Immunotherapy and Immune Responses (16 papers). Ravindra Uppaluri collaborates with scholars based in United States, France and Spain. Ravindra Uppaluri's co-authors include Robert D. Schreiber, Gavin P. Dunn, Jack D. Bui, J. Michael White, Cora D. Arthur, Elaine R. Mardis, Kathleen C. F. Sheehan, Clint Allen, James S. Lewis and Charles G. Rickert and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Ravindra Uppaluri

97 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

2012 932 citations Charles G. Rickert, Ravindra Uppaluri et al. profile →
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

2019 491 citations Ezra E.W. Cohen, Barbara Burtness et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ravindra Uppaluri United States	36	3.0k	2.5k	1.5k	785	716	100	5.2k
Tullia C. Bruno United States	42	4.2k 1.4×	4.4k 1.8×	1.6k 1.1×	1.0k 1.3×	748 1.0×	91	7.3k
Michele Del Vecchio Italy	34	3.6k 1.2×	1.5k 0.6×	1.9k 1.3×	993 1.3×	316 0.4×	169	5.1k
William H. Sharfman United States	32	4.6k 1.6×	2.0k 0.8×	1.2k 0.8×	1.3k 1.7×	362 0.5×	82	6.1k
Ágnes Bánkfalvi Germany	35	1.6k 0.5×	716 0.3×	1.7k 1.2×	566 0.7×	861 1.2×	136	4.2k
Thomas E. Darga United States	25	3.1k 1.1×	2.5k 1.0×	1.6k 1.1×	1.2k 1.5×	746 1.0×	34	5.4k
Gregory A. Daniels United States	28	3.3k 1.1×	1.5k 0.6×	2.4k 1.6×	1.2k 1.5×	1.5k 2.1×	116	6.0k
Liufu Deng China	22	4.0k 1.3×	4.5k 1.9×	1.8k 1.2×	1.2k 1.5×	554 0.8×	34	7.3k
Luigi Tornillo Switzerland	52	3.3k 1.1×	1.3k 0.5×	3.0k 2.0×	1.7k 2.2×	1.4k 2.0×	151	8.2k
Monica V. Goldberg United States	16	3.2k 1.1×	2.2k 0.9×	523 0.4×	643 0.8×	458 0.6×	18	4.5k
Jochen H. Lorch United States	32	2.9k 1.0×	601 0.2×	1.0k 0.7×	948 1.2×	520 0.7×	121	5.4k

Countries citing papers authored by Ravindra Uppaluri

Since Specialization

Citations

This map shows the geographic impact of Ravindra Uppaluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravindra Uppaluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravindra Uppaluri more than expected).

Fields of papers citing papers by Ravindra Uppaluri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravindra Uppaluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravindra Uppaluri. The network helps show where Ravindra Uppaluri may publish in the future.

Co-authorship network of co-authors of Ravindra Uppaluri

This figure shows the co-authorship network connecting the top 25 collaborators of Ravindra Uppaluri. A scholar is included among the top collaborators of Ravindra Uppaluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravindra Uppaluri. Ravindra Uppaluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Long, Georgina V., Robert I. Haddad, Caroline Robert, et al.. (2024). A randomized phase 2 trial of the IO102-IO103 (IDO and PD-L1) cancer vaccine plus pembrolizumab as neoadjuvant/adjuvant treatment of patients with solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS2701–TPS2701. 2 indexed citations

Klochikhin, A L, Robert I. Haddad, Amichay Meirovitz, et al.. (2023). KEYNOTE-689: A Phase 3 Study of Neoadjuvant and Adjuvant Pembrolizumab Plus Standard of Care (SOC) in Resectable, Locally Advanced (LA) Head and Neck Squamous Cell Carcinoma (HNSCC). European Journal of Surgical Oncology. 49(1). e9–e9. 3 indexed citations

Mishra, Shruti, Chong Hyun Suh, Regan W. Bergmark, et al.. (2021). Imaging features, therapies, and outcomes of fibrosing inflammatory pseudotumor of the nasopharynx: A systematic review. Journal of Neuroimaging. 32(2). 223–229.

Mudianto, Tenny, Katie M. Campbell, Jason A. Webb, et al.. (2021). Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas. Clinical Cancer Research. 27(8). 2326–2339. 18 indexed citations

Barnell, Erica K., Adam Waalkes, Kelsi Penewit, et al.. (2019). Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes. JCO Clinical Cancer Informatics. 3(3). 1–12. 6 indexed citations

Friedman, Jay, Ellen Moore, Paul Zolkind, et al.. (2019). Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells. Clinical Cancer Research. 26(3). 679–689. 57 indexed citations

Zhou, Liye, Tenny Mudianto, Xiaojing Ma, Rachel Riley, & Ravindra Uppaluri. (2019). Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti–PD-1 Resistance in Head and Neck Cancer. Clinical Cancer Research. 26(1). 290–300. 179 indexed citations

Gupta, Avni, Stephen T. Sonis, Ravindra Uppaluri, Regan W. Bergmark, & Alessandro Villa. (2019). Disparities in Oral Cancer Screening Among Dental Professionals: NHANES 2011–2016. American Journal of Preventive Medicine. 57(4). 447–457. 23 indexed citations

Hundal, Jasreet, Susanna Kiwala, Yang-Yang Feng, et al.. (2018). Accounting for proximal variants improves neoantigen prediction. Nature Genetics. 51(1). 175–179. 31 indexed citations

10.

Ainscough, Benjamin J., Erica K. Barnell, Peter Ronning, et al.. (2018). A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data. Nature Genetics. 50(12). 1735–1743. 50 indexed citations

11.

Chung, Man Ki, Young Ho Jung, Joon Kyoo Lee, et al.. (2017). CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug. Clinical Cancer Research. 24(3). 674–683. 39 indexed citations

12.

Johanns, Tanner M., Christopher A. Miller, Ian G. Dorward, et al.. (2016). Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy. Cancer Discovery. 6(11). 1230–1236. 209 indexed citations

13.

Moore, Ellen, Harrison Cash, Ravindra Uppaluri, et al.. (2016). Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers. Cancer Immunology Research. 4(7). 611–620. 81 indexed citations

14.

Onken, Michael D., Ashley E. Winkler, Krishna-Latha Kanchi, et al.. (2014). A Surprising Cross-Species Conservation in the Genomic Landscape of Mouse and Human Oral Cancer Identifies a Transcriptional Signature Predicting Metastatic Disease. Clinical Cancer Research. 20(11). 2873–2884. 83 indexed citations

15.

Lee, Sang‐Hun, Javier A. Carrero, Ravindra Uppaluri, et al.. (2013). Identifying the Initiating Events of Anti- Listeria Responses Using Mice with Conditional Loss of IFN-γ Receptor Subunit 1 (IFNGR1). The Journal of Immunology. 191(8). 4223–4234. 47 indexed citations

16.

Winkler, Ashley E., Joshua J. Brotman, Meredith E. Pittman, et al.. (2011). CXCR3 Enhances a T-Cell–Dependent Epidermal Proliferative Response and Promotes Skin Tumorigenesis. Cancer Research. 71(17). 5707–5716. 32 indexed citations

17.

Judd, Nancy P., Ashley E. Winkler, Oihana Murillo, et al.. (2011). ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness. Cancer Research. 72(1). 365–374. 172 indexed citations

18.

Conforti, Rosa, Yuting Ma, Yannis Morel, et al.. (2010). Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands. Cancer Research. 70(2). 490–500. 87 indexed citations

19.

Hackman, Trevor, Michael R. Chicoine, & Ravindra Uppaluri. (2009). Novel application of the palatal island flap for endoscopic skull base reconstruction. The Laryngoscope. 119(8). 1463–1466. 17 indexed citations

20.

Lieu, Judith E. C., et al.. (2005). Association of Reflux With Otitis Media in Children. Otolaryngology. 133(3). 357–361. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact